The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 21, 2023
Filed:
Jul. 21, 2020
Applicant:
Sloan-kettering Institute for Cancer Research, New York, NY (US);
Inventors:
Gabriela Chiosis, New York, NY (US);
Naga Vara Kishore Pillarsetty, Jackson Heights, NY (US);
Jason S. Lewis, New York, NY (US);
Steven M. Larson, New York, NY (US);
Tony Taldone, Forest Hills, NY (US);
Mary L. Alpaugh, Teaneck, NJ (US);
Erica M. Gomes-DaGama, New Rochelle, NY (US);
Assignee:
Sloan-Kettering Institute for Cancer Research, New York, NY (US);
Primary Examiner:
Int. Cl.
CPC ...
A61K 51/04 (2006.01); G01N 33/50 (2006.01); G01N 33/574 (2006.01); A61K 31/52 (2006.01);
U.S. Cl.
CPC ...
A61K 51/0459 (2013.01); A61K 31/52 (2013.01); G01N 33/5011 (2013.01); G01N 33/5017 (2013.01); G01N 33/574 (2013.01); G01N 33/57407 (2013.01); G01N 33/57426 (2013.01); G01N 33/5044 (2013.01); G01N 2500/04 (2013.01); G01N 2800/52 (2013.01);
Abstract
This invention concerns various methods of using labeled HSP90 inhibitors to improve treatment of cancer patients with HSP90 inhibitors, including ex vivo and in vivo methods for determining whether a tumor will likely respond to therapy with an HSP90 inhibitor.